- Corporate Officers - H
- Hollingsworth Jane H
Insider Trading History of Hollingsworth Jane H
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hollingsworth Jane H since 2011.
This trader's CIK number is 1297141.
At the time of last reporting, Hollingsworth Jane H was the Director of Cervomed Inc.. (stock ticker symbol CRVO).
Also see all insider trading activities at Cervomed Inc..
Note that in the past
Hollingsworth Jane H also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Nupathe Inc. (PATH) by Hollingsworth Jane H
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2011 | PATH | 20,000 | $51,280 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cervomed Inc. (CRVO) by Hollingsworth Jane H
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | CRVO | 0 | $0 | 0 | $0 | 671 | $0 |
2022 | CRVO | 0 | $0 | 0 | $0 | 732 | $0 |
2021 | CRVO | 32,786 | $19,999 | 0 | $0 | 0 | $0 |
Insider trading activities at 2 companies by Hollingsworth Jane H:
1. Nupathe Inc. (PATH)
2. Cervomed Inc. (CRVO)
Table 1. Insider trading of Nupathe Inc. (PATH) by Hollingsworth Jane H
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2011-09-09 | PATH | Buy | 20,000 | 2.56 | 51,280 |
Table 2. Insider trading of Cervomed Inc. (CRVO) by Hollingsworth Jane H
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-08-31 | CRVO | Option Ex | 122 | .00 | 0 |
2023-05-31 | DFFN | Option Ex | 183 | .00 | 0 |
2023-05-31 | DFFN | Option Ex | 183 | .00 | 0 |
2023-02-28 | DFFN | Option Ex | 183 | .00 | 0 |
2022-11-30 | DFFN | Option Ex | 183 | .00 | 0 |
2022-11-30 | DFFN | Option Ex | 183 | .00 | 0 |
2022-08-31 | DFFN | Option Ex | 183 | .00 | 0 |
2022-05-31 | DFFN | Option Ex | 183 | .00 | 0 |
2021-05-13 | DFFN | Buy | 32,786 | .61 | 19,999 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Hollingsworth Jane H
(Director of Cervomed Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.